PARP1 and colorectal carcinoma: Nascent ssDNA levels significantly increased only upon CHK1i + PARP1i (Fig. 3g), confirming that PARP1 inhibition boosts RS in neoR-CRC-SCs only when combined with ATRi/CHK1i.